Tirzepatide, a novel medication, is sparking significant excitement in the medical community as a potential treatment for both diabetes, type 2 and reducing body fat. This dual-action drug works by targeting two distinct receptors, GLP-1 and GIP, leading to better glucose control and notable slimming in research studies . While early results are pr